Shannon M MacDonald 1, Salahuddin Ahmad 2, Stefanos Kachris 3, Betty J Vogds 2, Melissa DeRouen 3, Alicia E Gitttleman 3, Keith DeWyngaert 3, Maria T Vlachaki.

Slides:

Advertisements

Similar presentations

Oncology management of CNS tumours Neil Burnet University of Cambridge Department of Oncology & Oncology Centre, Addenbrookes Hospital ECRIC CNS study.

Advertisements

Background/Purpose ATRT is a rare and aggressive CNS tumor usually presenting in very young children (age less than 5 years). Aggressive treatments have.

A phase I dose escalating study of intensity modulated radiation therapy (IMRT) for the treatment of glioblastoma multiforme (GBM) ( #1008) V. Stieber.

1 A study on the effect of set up errors and organ motion in patients treated with IMRT for prostate cancer S.C. Radioterapia Laboratorio di Fisica Medica.

Radiotherapy Planning for Esophageal Cancers Parag Sanghvi, MD, MSPH 9/12/07 Esophageal Cancer Tumor Board.

Para-spinal Tumors Encircling the Spinal Cord IMRT Comparison of Several Target Definitions.

Radiation Therapy (RT). What is cancer? Failure of the mechanisms that control growth and proliferation of the cells Uncontrolled (often rapid) growth.

Radiotherapy in prostate cancer Dr.Mina Tajvidi Radiation oncologist.

Direct Consideration of EUD Constraints in IMRT Optimization

What is radiation therapy (RT)? Cancer treatment Tumor versus normal tissues External photon beam RT.

Radiotherapy for Brain Tumours What do I need to know? Dr Matthew Foote Radiation Oncologist Princess Alexandra Hospital Queensland.

The Health Roundtable 1-1b_HRT1215-Session_HEGI_JOHNSON_WESTMEAD_NSW Volumetric Modulated Arc Therapy for Stereotactic Body Radiotherapy in Early Lung.

Clinical application of TCP ・ NTCP. Lyman JT. Complication probability as assessed from dosevolume histograms. Radiat Res Suppl 1985; 8:S13–S19. Because.

Results The measured-to-predicted dose ratio criteria used by the RPC to credential institutions is , however for this work, a criteria of

به نام خداوند بخشایندۀ بخشایشگر

Conformal Therapy for Lung Cancer B. Schicker, F.J. Schwab*, U. Götz Institute of Radiotherapy and Radiation Oncology St. Vincenz-Krankenhaus Limburg *Clinic.

Measurement of Dose to Critical Structures Surrounding the Prostate from Intensity-Modulated Radiation Therapy (IMRT) and Three Dimensional Conformal Radiation.

Comparison of Rectal Dose Volume Histograms for Definitive Prostate Radiotherapy Among Stereotactic Radiotherapy, IMRT, and 3D-CRT Techniques Author(s):

Evaluating a Nomogram for the Development of Radiation Pneumonitis in Locally Advanced Non-Small Cell Lung Cancer Treated with 3D and Intensity Modulated.

Data Mining to Aid Beam Angle Selection for IMRT Stuart Price-University of Maryland Bruce Golden- University of Maryland Edward Wasil- American University.

INTRODUCTION  The majority of clinical trials addressing outcomes in limited- stage small cell lung cancer (LS-SCLC) following definitive chemoradiotherapy.

Proton Therapy for Chondrosarcomas of the Skull Base and Cervical Spine: Long-term Experience at Loma Linda University Medical Center D. Y. Kim 2, R. W.

4D Stereotactic Lung IMRT Planning using Monte-Carlo Dose Calculations on Multiple RCCT-based Deformable Geometries Matthias Söhn1, Di Yan2 and Markus.

CTOS Soft Tissue Sarcoma of the Extremity Comparison of Conformal Post-operative Radiotherapy (CRT) and Intensity Modulated Radiotherapy (IMRT)

Phase III Clinical Trials with Protons: Their importance for Patient Centered Care for: NCI Workshop on Advanced Technologies in Radiation Oncology: Examining.

Clinico-Dosimetric Correlation for Acute and Chronic Gastrointestinal Toxicity in Patients of Locally Advanced Carcinoma Cervix Treated With Conventional.

Workshop on Advanced Technologies in Radiation Oncology Minesh Mehta.

Medical Accelerator F. Foppiano, M.G. Pia, M. Piergentili

Integrating the Health Care Enterprise- Radiation Oncology Use Case: In Vivo Patient Dosimetry Editor: Juan Carlos Celi - IBA Reviewer: Zheng Chang – Duke.

Clinical decisions in the optimization process I. Emphasis on tumor control issues Avi Eisbruch University of Michigan.

Department of Radiation Oncology University of Michigan Volumetric Arc treatment planning in the brain using synthetic CT images James M. Balter, Shu-Hui.

Laurie Cuttino MD, Dorin Todor PhD, Douglas Arthur MD, Rohini George, Lynn Pacyna CMD Medical College of Virginia Campus Department of Radiation Oncology.

A Tumour Control Probability based approach to the development of Plan Acceptance Criteria for Planning Target Volume in Intensity Modulated Radiation.

Cancer.orgPredict Results of a multicentric in silico clinical trial (ROCOCO): comparing radiotherapy with photons and protons for non-small cell lung.

A Comparison Between Two Leading Stereotactic Platforms in the Treatment of Multiple Metastases Sandra Vermeulen MD, James Raisis.

Optimization of Volumetric Modulated Arc Therapy (VMAT) Planning Strategy Using Ring-shaped ROI for Localized Prostate cancer Kentaro Ishii, Masako Hosono,

TLD POSTAL DOSE QUALITY AUDIT FOR 6MV AND 15MV PHOTON BEAMS IN RADIOTHERAPY CLINICAL PRACTICE Sonja Petkovska 1, Margarita Ginovska 2, Hristina Spasevska.

 Gy  Decreased fibrosis  Enhanced local control  Deep seeded tumors isch&source=hp&biw=1366&bih=624&q=radia.

A Proton Therapy Overview Richard Eckart And David Turberville Richard Eckart And David Turberville.

Saad El Din I, M.D *, Abd El AAl H, M.D *, Makaar W, M.D *, El Beih D, M.Sc †, Hashem W, M.Sc * *Department of Clinical Oncology and Radiotherapy, Kasr.

Purpose N-isopropylacrylamide (NIPAM) polymer gel dosimeters were employed to verify the dose distribution of clinical intensity modulated radiation therapy.

SARC018: A SARC PILOT MULTICENTER STUDY OF PREOPERATIVE RADIATION AND SURGERY IN PATIENTS WITH HIGH- RISK DESMOID TUMORS Robert S. Benjamin, M.D.

 Multidisciplinary Effort › Surgery › Radiation › Systemic Rx (chemo, “drugs”)

The Effects of Small Field Dosimetry on the Biological Models Used In Evaluating IMRT Dose Distributions Gene Cardarelli,PhD, MPH.

Understanding Radiation Therapy Lecturer Radiological Science

John Boyle, MD, Brad Ackerson, MD, Lin Gu, MS, Chris R. Kelsey, MD

Nasopharyngeal carcinoma

Neuroaxis Radiation for pediatric tumors (Medulloblastoma and Atypical teratoid/rhabdoid tumor) with VMAT (volumetric modulated arc therapy) and IMRT (intensity.

Intensity modulated radiation therapy for definitive treatment of paraortic relapse in patients with endometrial cancer Shervin M. Shirvani, MD, Ann.

A. Sánchez-Reyes. , N. López Vilanova+, A. Vila. , M. A. Duch+, A

Extending intracranial treatment options with Leksell Gamma Knife® Icon™ Key Statements from Customer Perspective by University Medical Centre Mannheim.

Feasibility of hippocampal sparing radiation therapy for glioblastoma using helical Tomotherapy Dr Kamalram THIPPU JAYAPRAKASH1,2,3, Dr Raj JENA1,4 and.

Introduction Materials & Methods Results Conclusion

RTOG 0126 A Phase III Randomized Study of High Dose 3D-CRT/IMRT versus Standard Dose 3D-CRT/IMRT in Patients Treated for Localized Prostate Cancer Bijoy.

Insert tables Insert figure

Insert tables Insert graphs Insert figure

Intensity modulated radiation therapy for definitive treatment of paraortic relapse in patients with endometrial cancer Shervin M. Shirvani, MD, Ann.

Volumetric Modulated Arc Therapy (VMAT) versus Intensity Modulated Radiation Therapy (IMRT) for Anal Carcinoma Heather Ortega, BSRT(T), CMD, Kerry Hibbitts,

Dosimetry of Alternative Techniques for Accelerated Partial Breast Irradiation Hanh Pham, B.S, CMD, Thanh Nguyen, BS, Christina Henson, MD, Salahuddin.

Insert tables Insert graphs Insert figure

Heart Dose Is an Independent Dosimetric Predictor of Overall Survival in Locally Advanced Non–Small Cell Lung Cancer Christina K. Speirs, MD, PhD, Todd.

Figure 4 Dosimetric comparison of LDR‑BT versus HDR‑BT

Figure 2 Nonmalignant tissue can be spared from radiation

Results of a Multicentric In Silico Clinical Trial (ROCOCO): Comparing Radiotherapy with Photons and Protons for Non-small Cell Lung Cancer Erik Roelofs,

Targeted Total Marrow Irradiation Using Three-Dimensional Image-Guided Tomographic Intensity-Modulated Radiation Therapy: An Alternative to Standard Total.

Advantages of intensity modulated proton therapy during hippocampal avoidance whole brain radiation therapy Joshua Stoker, Sujay Vora, Ameet Patel, David.

Technical Advances of Radiation Therapy for Thymic Malignancies

Hemithoracic Radiotherapy After Extrapleural Pneumonectomy for Malignant Pleural Mesothelioma: A Dosimetric Comparison of Two Well-Described Techniques

39/69 hormone replacement 9/69 Cerebrovascular events

Average Dose-Volume Ratio

Presentation transcript:

Shannon M MacDonald 1, Salahuddin Ahmad 2, Stefanos Kachris 3, Betty J Vogds 2, Melissa DeRouen 3, Alicia E Gitttleman 3, Keith DeWyngaert 3, Maria T Vlachaki 4 1 Massachusetts General Hospital 2 University of Oklahoma Health Sciences Center 3 New York University Medical Center 4 Wayne State University INTENSITY MODULATED RADIATION THERAPY VERSUS THREE DIMENSIONAL CONFORMAL RADIATION THERAPY FOR THE TREATMENT OF HIGH GRADE GLIOMA: A DOSIMETRIC COMPARISON

STUDY DESIGN Dosimetric comparison of IMRT versus 3DCRT in twenty patients with high-grade glioma. Prescribed Dose: 59.4 Gy, 33 fractions, 4-10 MV Dose constraints for brainstem: Gy Dose constraints for optic chiasm & nerves: Gy DVHs for target, brain, brainstem and optic nerves/chiasm were generated and compared TCP and NTCP were also calculated and compared

p= Brainstem % > 45Gy% > 54Gy Percent Organ Volume IMRT 3DCRT p=0.004 p=0.023 p=0.006 p=0.01 p=0.003 p≤ p= p=0.06 p=0. 01 p< p=0.059 p=0.015 p≤ COMPARISON OF TARGET AND NORMAL TISSUE DOSIMETRY: IMRT v. 3DCRT

Brainstem Brain Optic Chiasm PTVcd Target and Normal Tissue DVHs for one patient with L temporal lobe tumor

p≤0.001 p=0.015 p=0.091 p≤0.001 p=0.003 TCP as a function of clonogen cell density NTCP

CONCLUSIONS IMRT improved target coverage and tumor control probability. IMRT also improved sparing of normal brain, brainstem and optic chiasm. Combining IMRT with new more accurate tumor imaging tools and more effective systemic agents may allow us to increase tumor doses while minimizing toxicity and, therefore, improve outcomes in high grade glioma patients. CONCLUSIONS IMRT improved target coverage and tumor control probability. IMRT also improved sparing of normal brain, brainstem and optic chiasm. Combining IMRT with new more accurate tumor imaging tools and more effective systemic agents may allow us to increase tumor doses while minimizing toxicity and, therefore, improve outcomes in high grade glioma patients.